P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition

Autor: Najem, Ahmad, Krayem, Mohammad, Salès, François, Hussein, Nader, Badran, Bassam, Robert, Caroline, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Zdroj: In European Journal of Cancer September 2017 83:154-165
Databáze: ScienceDirect